Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure-Reference-Cited by-同舟云学术

Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure

Published:2004-01-01 Issue:1 Volume:27 Page:256-263
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Nesto Richard W.¹,Bell David¹,Bonow Robert O.¹,Fonseca Vivian¹,Grundy Scott M.¹,Horton Edward S.¹,Le Winter Martin¹,Porte Daniel¹,Semenkovich Clay F.¹,Smith Sidney¹,Young Lawrence H.¹,Kahn Richard¹

Affiliation:

1. From the American Diabetes Association and the American Heart Association

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/27/1/256/563489/zdc00104000256.pdf

Reference51 articles.

1. Nesto R, Libby P: Diabetes mellitus and the cardiovascular system. In Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed. Braunwald E, Zipes DP, Libby P, Eds. Philadelphia, PA, W.B. Saunders, 2001, p. 2133–2150

2. Young LH, Chyun DA: Heart disease in patients with diabetes. In Ellenberg and Rifkin’s Diabetes Mellitus: Theory and Practice. 6th ed. Porter D, Baron A, Sherwin R, Eds. New York, NY, McGraw-Hill, Medical Pub Division, 2003, p. 823–844

3. Martens FM, Visseren FL, Lemay J, et al.: Metabolic and additional vascular effects of thiazolidinediones. Drugs 62:1463–1480, 2002

4. Avandia (rosiglitazone maleate) [package insert]. Philadelphia, PA, GlaxoSmithKline Pharmaceuticals, 2000

5. Actos (pioglitazone hydrochloride) [package insert]. Lincolnshire, IL, Takeda Pharmaceuticals America, 2000

Cited by 499 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pan-PPAR agonist E17241 ameliorates hyperglycemia and diabetic dyslipidemia in KKAy mice via up-regulating ABCA1 in islet, liver, and white adipose tissue;Biomedicine & Pharmacotherapy;2024-03

2. Genistein enhances NAD+ biosynthesis by upregulating nicotinamide phosphoribosyltransferase in adipocytes;The Journal of Nutritional Biochemistry;2023-11

3. Reduction in Obesity-Related Hepatic Fibrosis by SR1664;Biology;2023-09-26

4. The Chronic Systolic Heart Failure Patient: Presentation and Management;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

5. IRW prevents diet-induced non-alcoholic fatty liver disease by preserving mitochondrial content and enhancing hepatic fatty acid oxidation capacity;2023-08-09